PubMedopen access
Helicase-primase inhibitors as next-generation anti-HSV agents: from current clinical status to structure-activity relationships and patent coverage.
humans, antiviral agents, structure-activity relationship, patents as topic, dna primase, animals
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 631505
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.